Neurol. praxi. 2017;18(1):9-10

Neuromuskulární komplikace farmakoterapie

MUDr. Eva Vlčková, Ph.D.
Neurologická klinika Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno

Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vlčková E. Neuromuskulární komplikace farmakoterapie. Neurol. praxi. 2017;18(1):9-10.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bednařík J, Vlčková E, Horák T. Statinová myopatie. Neurol. praxi 2017; 18(1): 15-19 Go to original source...
    2. Ehler E, Zámečník J. Toxické myopatie. Neurol. praxi 2016; 17(6): 386-390. Go to original source...
    3. Davies EC, Green CF, Mottram DR, Pirmohamed M. Adverse drug reactions in hospitals: a narrative review. Curr Drug Saf 2007; 2(1): 79-87. Go to original source... Go to PubMed...
    4. Infolisty Státního ústavu pro kontrolu léčiv 2013. Dostupné na: http://www.olecich.cz/uploads/infoLISTY/SUKL_Infolisty_2013_07.pdf.
    5. Karam C, Dyck PJ. Toxic Neuropathies. Semin Neurol 2015; 35(4): 448-457. doi: 10.1055/s-0035-1558977. Go to original source... Go to PubMed...
    6. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200-5. Go to original source... Go to PubMed...
    7. London Z, Albers JW. Toxic neuropathies associated with pharmaceutic and industrial agents. Neurol Clin 2007; 25(1): 257-276. Go to original source... Go to PubMed...
    8. Marsh S, Pittard A. Neuromuscular disorders and anaesthesia. Part 2: specific neuromuscular disorders. Continuing Education in Anaesthesia, Critical Care & Pain 2011; 11 (4): 119-123. Go to original source...
    9. Mastaglia FL, Needham M. Update on toxic myopathies. Curr Neurol Neurosci Rep 2012; 12(1): 54-61. Go to original source... Go to PubMed...
    10. Mazanec R, Baumgartner D, Potočková V. Toxické neuropatie. Neurol. praxi 2017; 18(1): 20-24. Go to original source...
    11. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15-9. Go to original source... Go to PubMed...
    12. Raputová J, Vlčková E, ©mardová L, Rajdová A, Janíková A. Polyneuropatie indukovaná chemoterapií. Neurol. praxi 2017; 18(1): 25-31 Go to original source...
    13. Topinková E, Fialová D, Býma S, Matějovská-Kubeąová H. Racionální farmakoterapie geriatrických pacientů. Doporučení pro praktické lékaře 2014. Dostupné na: http://www.svl.cz/files/files/Doporucene-postupy-od-2013/DP-Geriatrie-2014.pdf
    14. Voháňka S. Léky a nervosvalový přenos. Neurol. praxi 2017; 18(1): 11-14. Go to original source...
    15. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst 2008; 13(1): 27-46. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.